Tagged Articles

PMS 22 articles

Drug company ‘check lists’ influence patient choice

How ethical is it for pharmaceutical companies to target consumers with advertising for their prescription drugs? Consider this: The United States is one of only four countries that allow direct-to-consumer advertising. (The others are New Zealand, Bangladesh, and South Korea.) What the public is more apt to see or read about a drug is not breaking news or scientific studies, but rather advertiser-crafted sound bites or celebrity endorsements of medications heavily advertised on television and magazines. Rather than relying on the guidance of a health care professional to determine the best drug for a patient, patients now enter doctor’s offices ... Read More

Combined birth control pills provide limited PMS pain improvement

Combined birth control pills can help reduce the pain of menstrual cramps, but not much, according to a Swedish longitudinal study. Combined oral contraceptives contain two hormones – estrogen and progestin. They work by stopping ovulation and by making the lining of the uterus thinner. There are several hormone varieties of combined birth control pills. The study wasn’t limited to a particular formulation; however, some birth control pills are also approved by the Food and Drug Administration (FDA) to treat acne, such as OrthoTri-cylclen, and another, Yaz, has been approved to treat the symptoms of PMDD, a more severe form ... Read More

Birth control called ‘secondary cause of death’ in young woman taking Yaz

It was mere hours after Rebecca Bapp called her parents to say that she wasn’t feeling well that the 21-year-old was dead. Mysteriously, her health declined so rapidly even doctors were baffled by what was making her so ill. Not long after her parents rushed her to the hospital, she was placed on a breathing machine and sedated. She coded three times before she gave up her fight for life. Confused by her daughter’s sudden illness, Rebecca’s parents ordered an autopsy. The primary cause of death was a blood clot in her heart. “The secondary cause of death was her ... Read More

Why would FDA panel not ban Yaz over blood clot risk?

Why did an advisory panel of experts for the Food and Drug Administration (FDA) not vote to ban the popular birth control pill Yaz and other pills of its generation containing the hormone drospirenone, instead opting to recommend that the pills carry a stronger warning for life-threatening blood clots? There is no doubt that with all oral contraceptives there is a slight risk for blood clots. Bayer, maker of Yaz and a family of other drospirenone-containing pills such as Yasmin, Beyaz and Safyral, has consistently claimed its pills were no more as dangerous than other birth control pills. However, newer ... Read More

FDA panel recommends stricter blood clot warnings on Yaz

Packs of Yaz and other birth control pills containing the hormone drospirenone should be updated to include a warning that the pills may be more likely to cause life threatening blood clots than older oral contraceptives, according to a Food and Drug Administration (FDA) advisory panel. The expert board was charged by the FDA with reviewing new data on the safety of the pills and recommending what action the federal agency should take. Yaz, made by Bayer, is a newer generation birth control pill that contains the manmade hormone drospirenone, which is designed to mimic the naturally occurring female hormone ... Read More

Bayer dismisses new studies showing higher blood clot risk with Yaz, Yasmin

Bayer isn’t backing down. The pharmaceutical giant that is making billions off sales of it’s popular birth control pills Yaz and Yasmin, says two new studies that suggest the company’s oral contraceptives put women at greater risk for blood clots than older generation pills, are flawed. “Given the already large and robust scientific body of evidence, in Bayer’s opinion, these studies do not change the overall assessment about the safety of Bayer’s oral contraceptives,” the company said in a statement. Yaz and Yasmin are considered “fourth generation” birth control pills and use the hormones ethinyl estradiol and drospirenone. Bayer heavily ... Read More

Alert your friends to the dangers of Yaz, Yasmin

When Yaz and Yasmin hit the market, they were touted to be different than other birth control pills because they could curb the annoying symptoms of premenstrual syndrome (PMS) and even clear up unsightly acne. The marketing campaign worked quite well for Bayer HealthCare. The pills became the No. 1 selling oral contraceptives in the United States, with many of its users being young women and teenagers who asked their doctors for the pills by name. But the honeymoon would soon end for Bayer, as reports of potentially fatal side effects from Yaz and Yasmin began to surface. Bayer was ... Read More

Parody of BCP commercials does not diminish safety concerns

Sarah Haskins of Target Women, a recurring segment on Current TV’s weekly television show, infoMania, is known to some for her take on the often-ridiculous way the media reaches out to women. In this episode she tackles birth control commercials from Seasonique, Yaz and NuvaRing. Sarah’s take on the commercials is hysterical, but the ads alone are often comical with women kicking away signs of irritability and moodiness, and cartoon girls diving into pools. “We all know that birth control pills are 99.9 percent effective at preventing pregnancy. But did you know there is a pill that can do more?” ... Read More

Mother warns others of the dangers of Yaz

The year Leah Mayfield died, Bayer HealthCare made $600 million on its popular birth control pill, Yaz. The drug, also known by the brand name Yasmin and the generic brand Ocella, was touted for the added benefit of stomping out the bothersome symptoms of severe premenstrual syndrome, or premenstrual dysphoric disorder (PMDD). It is the combination of ethinyl estradiol and the diuretic drospirenone that make Yaz different than other birth control pills. But that combination has proven deadly to numerous women who have taken it, including 20-year-old Leah. The Tennessee Tech student had been taking the drug for about six ... Read More

Southern Illinois district court to handle Yaz lawsuits

The Judicial Panel on Multidistrict Litigation in Washington D.C. has chosen the U.S. District Court in the Southern District of Illinois in East St. Louis to handle multidistrict litigation for what could be as many as 25,000 Yaz lawsuits. Chief Judge David Herndon will preside over the pre-trial proceedings, which have been filed by plaintiffs in all parts of the country against Bayer, the manufacturer of the popular oral contraceptive. Yaz incorporates a unique progestin, drospirenone, with ethinyl estradiol, a more common ingredient used in birth control drugs. Many women who have been injured after starting a Yaz regimen allege ... Read More